The vascular stent market size has grown rapidly in recent years. It will grow from $17.25 billion in 2025 to $19.11 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, expansion of catheterization laboratories, rising adoption of angioplasty procedures, growth in aging population, improved access to interventional cardiology.
The vascular stent market size is expected to see rapid growth in the next few years. It will grow to $28.21 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing demand for next-generation stent technologies, rising focus on personalized cardiovascular treatments, expansion of minimally invasive cardiac care, growing investments in advanced biomaterials, increasing adoption of digital imaging-guided interventions. Major trends in the forecast period include increasing adoption of drug-eluting and bioresorbable stents, rising demand for minimally invasive vascular procedures, growing use of advanced alloy and polymer materials, expansion of peripheral vascular interventions, enhanced focus on long-term restenosis prevention.
The rise in healthcare expenditure is anticipated to boost the growth of the vascular stent market. Healthcare expenditure refers to the total resources allocated, typically measured in monetary terms, by a country, organization, or individual for healthcare-related goods and services over a specific period. Higher healthcare spending leads to better infrastructure, enhanced healthcare facilities, and increased awareness, all of which positively influence the diagnosis and treatment of vascular diseases. For example, in June 2023, the Centers for Medicare & Medicaid Services (CMS), a U.S.-based organization that administers major healthcare programs, reported in the National Health Expenditure Projections 2023-2024 that health expenditure growth rates in the United States are expected to be 5% this year and 5.1% the following year. Consequently, rising healthcare expenditure is propelling the vascular stent market forward.
Major companies are strategically partnering with start-ups and mid-sized firms in the vascular stent market to expand their product and service offerings. Such collaborations and partnership agreements enable companies to enhance their existing product portfolios and extend their geographical reach. For instance, in September 2023, The Electrospinning Company, a UK-based manufacturer of advanced biomaterials for implantable tissue-regenerative devices, collaborated with Relisys Medical Devices, an India-based producer of highly innovative cardiovascular medical devices, to develop groundbreaking products that could enhance cardiovascular care and transform patient outcomes. Through this partnership, the Electrospinning Company’s Caladrix technology allows for the deposition of a thin, functional polymer coating without the need for sutures, enabling the manufacturing of vascular stents with improved production rates and yields while maintaining efficacy.
In January 2024, Olympus Corporation, a Japan-based company specializing in the development, manufacture, and sale of medical technology and precision instruments, acquired Taewoong Medical Co., Ltd. for $0.37 billion. This acquisition is intended to strengthen Olympus Corporation's gastrointestinal product portfolio, enhance patient outcomes, and broaden its global market presence in the GI medical device sector. Taewoong Medical Co., Ltd., a manufacturing company based in South Korea, produces vascular stents designed to treat narrowed blood vessels and improve circulation.
Major companies operating in the vascular stent market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Cook Medical, W. L. Gore & Associates, Meril Life Sciences, Sahajanand Medical Technologies, Translumina, Lepu Medical Technology, Stentys, Endologix, JOTEC, Hexacath, iVascular, Balton, Opto Circuits.
North America was the largest region in the vascular stent market share in 2025. The regions covered in the vascular stent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the vascular stent market by increasing costs of imported cobalt-chromium alloys, nitinol materials, polymers, precision manufacturing equipment, and sterilization technologies. Cardiac centers and hospitals in North America and Europe are most affected due to reliance on imported high-precision stents, while Asia-Pacific faces higher export manufacturing costs. These tariffs are increasing device prices and procurement costs. However, they are also encouraging localized stent manufacturing, regional material sourcing, and innovation in cost-efficient stent designs.
The vascular stent market research report is one of a series of new reports that provides vascular stent market statistics, including vascular stent industry global market size, regional shares, competitors with a vascular stent market share, detailed vascular stent market segments, market trends and opportunities, and any further data you may need to thrive in the vascular stent industry. This vascular stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vascular stents are intricately designed metal mesh tubes utilized in medical procedures to prevent vessel closure and enhance blood flow in narrowed or blocked veins and arteries. This intervention, commonly referred to as 'vascular stenting,' aims to minimize the risk of late restenosis while supporting swift recovery by widening obstructed arteries, thus reducing the likelihood of infections and physical complications.
The primary categories of vascular stent products include coronary stents, peripheral vascular stents, and EVAR stent grafts. Coronary stents specifically target constricted arteries supplying oxygenated blood to the heart, playing a crucial role in maintaining arterial patency post-angioplasty. Within the vascular stent market, these stents encompass various types such as bare metal stents, bio-engineered and bioresorbable vascular scaffolds, drug-eluting stents, and dual therapy stents. These stents are crafted from materials like cobalt-chromium, platinum-chromium, nickel titanium, stainless steel, and polymers. Their deployment methods involve balloon-expandable and self-expanding stents, utilized across ambulatory surgical centers, cardiac facilities, and hospitals.
The vascular stent market consists of sales of bare metal stents, bioresorbable scaffold systems, and drug-eluting balloons. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The vascular stent market size is expected to see rapid growth in the next few years. It will grow to $28.21 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing demand for next-generation stent technologies, rising focus on personalized cardiovascular treatments, expansion of minimally invasive cardiac care, growing investments in advanced biomaterials, increasing adoption of digital imaging-guided interventions. Major trends in the forecast period include increasing adoption of drug-eluting and bioresorbable stents, rising demand for minimally invasive vascular procedures, growing use of advanced alloy and polymer materials, expansion of peripheral vascular interventions, enhanced focus on long-term restenosis prevention.
The rise in healthcare expenditure is anticipated to boost the growth of the vascular stent market. Healthcare expenditure refers to the total resources allocated, typically measured in monetary terms, by a country, organization, or individual for healthcare-related goods and services over a specific period. Higher healthcare spending leads to better infrastructure, enhanced healthcare facilities, and increased awareness, all of which positively influence the diagnosis and treatment of vascular diseases. For example, in June 2023, the Centers for Medicare & Medicaid Services (CMS), a U.S.-based organization that administers major healthcare programs, reported in the National Health Expenditure Projections 2023-2024 that health expenditure growth rates in the United States are expected to be 5% this year and 5.1% the following year. Consequently, rising healthcare expenditure is propelling the vascular stent market forward.
Major companies are strategically partnering with start-ups and mid-sized firms in the vascular stent market to expand their product and service offerings. Such collaborations and partnership agreements enable companies to enhance their existing product portfolios and extend their geographical reach. For instance, in September 2023, The Electrospinning Company, a UK-based manufacturer of advanced biomaterials for implantable tissue-regenerative devices, collaborated with Relisys Medical Devices, an India-based producer of highly innovative cardiovascular medical devices, to develop groundbreaking products that could enhance cardiovascular care and transform patient outcomes. Through this partnership, the Electrospinning Company’s Caladrix technology allows for the deposition of a thin, functional polymer coating without the need for sutures, enabling the manufacturing of vascular stents with improved production rates and yields while maintaining efficacy.
In January 2024, Olympus Corporation, a Japan-based company specializing in the development, manufacture, and sale of medical technology and precision instruments, acquired Taewoong Medical Co., Ltd. for $0.37 billion. This acquisition is intended to strengthen Olympus Corporation's gastrointestinal product portfolio, enhance patient outcomes, and broaden its global market presence in the GI medical device sector. Taewoong Medical Co., Ltd., a manufacturing company based in South Korea, produces vascular stents designed to treat narrowed blood vessels and improve circulation.
Major companies operating in the vascular stent market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Cook Medical, W. L. Gore & Associates, Meril Life Sciences, Sahajanand Medical Technologies, Translumina, Lepu Medical Technology, Stentys, Endologix, JOTEC, Hexacath, iVascular, Balton, Opto Circuits.
North America was the largest region in the vascular stent market share in 2025. The regions covered in the vascular stent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the vascular stent market by increasing costs of imported cobalt-chromium alloys, nitinol materials, polymers, precision manufacturing equipment, and sterilization technologies. Cardiac centers and hospitals in North America and Europe are most affected due to reliance on imported high-precision stents, while Asia-Pacific faces higher export manufacturing costs. These tariffs are increasing device prices and procurement costs. However, they are also encouraging localized stent manufacturing, regional material sourcing, and innovation in cost-efficient stent designs.
The vascular stent market research report is one of a series of new reports that provides vascular stent market statistics, including vascular stent industry global market size, regional shares, competitors with a vascular stent market share, detailed vascular stent market segments, market trends and opportunities, and any further data you may need to thrive in the vascular stent industry. This vascular stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vascular stents are intricately designed metal mesh tubes utilized in medical procedures to prevent vessel closure and enhance blood flow in narrowed or blocked veins and arteries. This intervention, commonly referred to as 'vascular stenting,' aims to minimize the risk of late restenosis while supporting swift recovery by widening obstructed arteries, thus reducing the likelihood of infections and physical complications.
The primary categories of vascular stent products include coronary stents, peripheral vascular stents, and EVAR stent grafts. Coronary stents specifically target constricted arteries supplying oxygenated blood to the heart, playing a crucial role in maintaining arterial patency post-angioplasty. Within the vascular stent market, these stents encompass various types such as bare metal stents, bio-engineered and bioresorbable vascular scaffolds, drug-eluting stents, and dual therapy stents. These stents are crafted from materials like cobalt-chromium, platinum-chromium, nickel titanium, stainless steel, and polymers. Their deployment methods involve balloon-expandable and self-expanding stents, utilized across ambulatory surgical centers, cardiac facilities, and hospitals.
The vascular stent market consists of sales of bare metal stents, bioresorbable scaffold systems, and drug-eluting balloons. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Vascular Stent Market Characteristics
3. Vascular Stent Market Supply Chain Analysis
4. Global Vascular Stent Market Trends and Strategies
5. Vascular Stent Market Analysis of End Use Industries
7. Global Vascular Stent Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Vascular Stent Total Addressable Market (TAM) Analysis for the Market
9. Vascular Stent Market Segmentation
10. Vascular Stent Market Regional and Country Analysis
11. Asia-Pacific Vascular Stent Market
12. China Vascular Stent Market
13. India Vascular Stent Market
14. Japan Vascular Stent Market
15. Australia Vascular Stent Market
16. Indonesia Vascular Stent Market
17. South Korea Vascular Stent Market
18. Taiwan Vascular Stent Market
19. South East Asia Vascular Stent Market
20. Western Europe Vascular Stent Market
21. UK Vascular Stent Market
22. Germany Vascular Stent Market
23. France Vascular Stent Market
24. Italy Vascular Stent Market
25. Spain Vascular Stent Market
26. Eastern Europe Vascular Stent Market
27. Russia Vascular Stent Market
28. North America Vascular Stent Market
29. USA Vascular Stent Market
30. Canada Vascular Stent Market
31. South America Vascular Stent Market
32. Brazil Vascular Stent Market
33. Middle East Vascular Stent Market
34. Africa Vascular Stent Market
36. Vascular Stent Market Competitive Landscape and Company Profiles
37. Vascular Stent Market Other Major and Innovative Companies
40. Vascular Stent Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Vascular Stent Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses vascular stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for vascular stent? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular stent market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Coronary Stents; Peripheral Vascular Stents2) By Material: Metallic Stents; Cobalt-Chromium; Platinum Chromium; Nickel Titanium; Stainless Steel
3) By Mode Of Delivery: Balloon-Expandable Stent; Self-Expanding Stent
4) By End-User: Ambulatory Surgical Center; Cardiac Center; Hospital
Subsegments:
1) By Coronary Stents: Drug-Eluting Coronary Stents; Bare Metal Coronary Stents2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents; Bare Metal Peripheral Stents
Companies Mentioned: Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Biotronik SE & Co. KG; Terumo Corporation; MicroPort Scientific Corporation; B. Braun Melsungen AG; Cook Medical; W. L. Gore & Associates; Meril Life Sciences; Sahajanand Medical Technologies; Translumina; Lepu Medical Technology; Stentys; Endologix; JOTEC; Hexacath; iVascular; Balton; Opto Circuits
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Vascular Stent market report include:- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Terumo Corporation
- MicroPort Scientific Corporation
- B. Braun Melsungen AG
- Cook Medical
- W. L. Gore & Associates
- Meril Life Sciences
- Sahajanand Medical Technologies
- Translumina
- Lepu Medical Technology
- Stentys
- Endologix
- JOTEC
- Hexacath
- iVascular
- Balton
- Opto Circuits
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 19.11 Billion |
| Forecasted Market Value ( USD | $ 28.21 Billion |
| Compound Annual Growth Rate | 10.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
